NICE propose to charge £142,000 to conduct single technology appraisals from May 2017.
Read more HERE
NICE propose to charge £142,000 to conduct single technology appraisals from May 2017.
Read more HERE
NHS takes a bold step towards achieving net zero by decommissioning desflurane due to its high globa...
Read moreWe discuss the 2024 VPAG agreement, how it differs from the previous VPAS and whether this will impa...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch